Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Corash

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Current Hematology Reports|October 17, 2003
Pathogen reduction technology: methods, status of clinical trials, and future prospectsLaurence Corash
Expert Review of Hematology|September 24, 2011
Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsisLaurence Corash
International Journal of Hematology|December 24, 2004
Economics of pathogen inactivation technology for platelet concentrates in JapanUlf Staginnus, Laurence Corash
Transfusion|March 23, 2016
The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction treatment modelLaurence Corash, Richard J Benjamin
Transfusion|October 12, 2011
Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatmentAnne North, Vic Ciaravino, Nina Mufti, et al.
Pathogens (Basel, Switzerland)|May 4, 2026
Pathogen Reduction of Transfused Blood Components-The End of the Beginning Rather than the Beginning of the EndAlbert Farrugia, Laurence Corash, Raymond Goodrich, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 15, 2022
Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?Marissa Li, Johannes Irsch, Laurence Corash, et al.
Transfusion|July 29, 2010
The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivationWeiqun Liu, George D Cimino, Laurence Corash, et al.
Analytical Chemistry|March 8, 2008
LC-MS/MS for the detection of DNA interstrand cross-links formed by 8-methoxypsoralen and UVA irradiation in human cellsHuachuan Cao, John E Hearst, Laurence Corash, et al.
Transfusion|January 14, 2020
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathioneAnne K North, Nina Mufti, Theresa Sullivan, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Hematology Reports|October 17, 2003
Pathogen reduction technology: methods, status of clinical trials, and future prospectsLaurence Corash
Expert Review of Hematology|September 24, 2011
Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsisLaurence Corash
International Journal of Hematology|December 24, 2004
Economics of pathogen inactivation technology for platelet concentrates in JapanUlf Staginnus, Laurence Corash
Transfusion|March 23, 2016
The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction treatment modelLaurence Corash, Richard J Benjamin
Transfusion|October 12, 2011
Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatmentAnne North, Vic Ciaravino, Nina Mufti, et al.
Pathogens (Basel, Switzerland)|May 4, 2026
Pathogen Reduction of Transfused Blood Components-The End of the Beginning Rather than the Beginning of the EndAlbert Farrugia, Laurence Corash, Raymond Goodrich, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 15, 2022
Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?Marissa Li, Johannes Irsch, Laurence Corash, et al.
Transfusion|July 29, 2010
The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivationWeiqun Liu, George D Cimino, Laurence Corash, et al.
Analytical Chemistry|March 8, 2008
LC-MS/MS for the detection of DNA interstrand cross-links formed by 8-methoxypsoralen and UVA irradiation in human cellsHuachuan Cao, John E Hearst, Laurence Corash, et al.
Transfusion|January 14, 2020
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathioneAnne K North, Nina Mufti, Theresa Sullivan, et al.
Pageof 7